COMMUNIQUÉS West-GlobeNewswire

Castle Biosciences to Acquire Previse
05/05/2025
Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, [...]
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
05/05/2025
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the [...]
Context Therapeutics Announces Chief Medical Officer Transition
05/05/2025
Board Member Dr. Karen Smith to serve as Interim Chief Medical Officer PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical [...]
Castle Biosciences Reports First Quarter 2025 Results
05/05/2025
Q 1 2025 revenue increased 21% over Q 1 2024 to $88 million Q 1 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, DecisionDx ® -SCC, TissueCypher ® ) increased 33% over Q 1 2024 Raising full- [...]
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance
05/05/2025
Achieved ~25% worldwide revenue growth and positive adjusted EBITDA First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9 [...]
Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update
05/05/2025
Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June [...]
Certara Reports First Quarter 2025 Financial Results
05/05/2025
Reiterates Full Year 2025 Financial Guidance RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the [...]
DBV Technologies participera à la conférence Citizens JMP Life Sciences
05/05/2025
Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société [...]
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
05/05/2025
Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/05/2025
MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
05/05/2025
BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on [...]
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
05/05/2025
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold [...]
HNL Lab Medicine Fuels Student Success
05/05/2025
ALLENTOWN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is proud to announce its partnership with South Mountain Middle School as part of the United Way of the Greater Lehigh Valley’s Community Schools program [...]
Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
05/05/2025
EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
05/05/2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane [...]
Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!
05/05/2025
New Review Explores Arialief’s Side Effects, Complaints, Ingredients, and Nerve-Calming Formula for Neuropathy Relief ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- If you’re reading this, chances are you, or someone [...]
Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!
05/05/2025
ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Arialief is a thoughtfully designed natural nerve pain relief supplement that can address the root issues behind various symptoms associated with neuropathy. It is backed [...]
Coloplast A/S CEO Kristian Villumsen steps down as of today
05/05/2025
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy period, the Board [...]
AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA
05/05/2025
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE [...]

Pages